Adynxx, Inc.
US ˙ OTCPK ˙ US00784D1037

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Nicole Vitullo. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Nicole Vitullo reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:ESPR / Esperion Therapeutics, Inc. Director 36,918
US:MRNS / Marinus Pharmaceuticals, Inc. Director 12,375
Director 0
10% Owner 187,500
US:ADYX / Adynxx, Inc. 10% Owner 45,054
US:BNGO / Bionano Genomics, Inc. 10% Owner 15,000
US:DRNA / Dicerna Pharmaceuticals Inc 10% Owner 0
US:OCRX / Ocera Therapeutics, Inc. 10% Owner 0
US:TBRA / Tobira Therapeutics, Inc. 10% Owner 0
US:CLCD / CoLucid Pharmaceuticals, Inc. 10% Owner 0
Director 0
US:EVOK / Evoke Pharma, Inc. 10% Owner 10,328
US:SNDX / Syndax Pharmaceuticals, Inc. 10% Owner 0
US:GKOS / Glaukos Corporation 10% Owner 0
US:LIFE / Ethos Technologies Inc. 10% Owner 0
US:NEOT / Neothetics, Inc. 10% Owner 0
US:DRTX / Durata Therapeutics Inc Director, 10% Owner 0
US:ATRA / Atara Biotherapeutics, Inc. 10% Owner 0
US:VCYT / Veracyte, Inc. 10% Owner 2,763,294
US:OTIC / Otonomy Inc 10% Owner 0
US:ALDX / Aldeyra Therapeutics, Inc. 10% Owner 0
10% Owner 0
US:AKAO / Achaogen, Inc. 10% Owner 0
US:ALIM / Alimera Sciences, Inc. 10% Owner 34,907
US:TNDM / Tandem Diabetes Care, Inc. 10% Owner 6,008
US:CLVS / Clovis Oncology Inc 10% Owner 2,581,745
US:NUVA / Nuvasive Inc 10% Owner 8,000
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Nicole Vitullo. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas ADYX / Adynxx, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ADYX / Adynxx, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ADYX / Adynxx, Inc. Insider Trades
Vendas Internas ADYX / Adynxx, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ADYX / Adynxx, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ADYX / Adynxx, Inc. Insider Trades
Compras Internas ALDX / Aldeyra Therapeutics, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ADYX / Adynxx, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ALDX / Aldeyra Therapeutics, Inc. Insider Trades
Vendas Internas ALDX / Aldeyra Therapeutics, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ADYX / Adynxx, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ALDX / Aldeyra Therapeutics, Inc. Insider Trades
Compras Internas ATRA / Atara Biotherapeutics, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ADYX / Adynxx, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2014-10-21 ATRA DP VIII Associates, L.P. 1,841 11.0000 74 275.0000 20,251 184 1600.5 96,586 476.94
2014-10-21 ATRA Domain Partners VIII, L.P. 248,159 11.0000 9,926 275.0000 2,729,749

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ATRA / Atara Biotherapeutics, Inc. Insider Trades
Vendas Internas ATRA / Atara Biotherapeutics, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ADYX / Adynxx, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ATRA / Atara Biotherapeutics, Inc. Insider Trades
Compras Internas ATYR / aTyr Pharma, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ADYX / Adynxx, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ATYR / aTyr Pharma, Inc. Insider Trades
Vendas Internas ATYR / aTyr Pharma, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ADYX / Adynxx, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ATYR / aTyr Pharma, Inc. Insider Trades
Compras Internas BNGO / Bionano Genomics, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ADYX / Adynxx, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2018-08-23 BNGO Domain Partners VIII, L.P. 15,000 6.1250 429 214.3750 91,875 35 82.5 -56,565 -61.57

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

BNGO / Bionano Genomics, Inc. Insider Trades
Vendas Internas BNGO / Bionano Genomics, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ADYX / Adynxx, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

BNGO / Bionano Genomics, Inc. Insider Trades
Compras Internas ESPR / Esperion Therapeutics, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ADYX / Adynxx, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2014-10-21 ESPR DOMAIN PARTERS VII L P 500,000 20.0000 500,000 20.0000 10,000,000 210 115.3000 47,650,000 476.50

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ESPR / Esperion Therapeutics, Inc. Insider Trades
Vendas Internas ESPR / Esperion Therapeutics, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ADYX / Adynxx, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2019-03-19 ESPR VITULLO NICOLE 13,629 44.6600 13,629 44.6600 608,671 363 27.44 -234,691 -38.56
2019-03-19 ESPR VITULLO NICOLE 1,700 45.2500 1,700 45.2500 76,925
2018-01-25 ESPR VITULLO NICOLE 11,674 71.7900 11,674 71.7900 838,076
2017-12-06 ESPR VITULLO NICOLE 9,326 53.8500 9,326 53.8500 502,205

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ESPR / Esperion Therapeutics, Inc. Insider Trades
Compras Internas GKOS / Glaukos Corporation - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ADYX / Adynxx, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

GKOS / Glaukos Corporation Insider Trades
Vendas Internas GKOS / Glaukos Corporation - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ADYX / Adynxx, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

GKOS / Glaukos Corporation Insider Trades
Compras Internas SNDX / Syndax Pharmaceuticals, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ADYX / Adynxx, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

SNDX / Syndax Pharmaceuticals, Inc. Insider Trades
Vendas Internas SNDX / Syndax Pharmaceuticals, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ADYX / Adynxx, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

SNDX / Syndax Pharmaceuticals, Inc. Insider Trades
Compras Internas VCYT / Veracyte, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ADYX / Adynxx, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

VCYT / Veracyte, Inc. Insider Trades
Vendas Internas VCYT / Veracyte, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ADYX / Adynxx, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

VCYT / Veracyte, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Nicole Vitullo conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2023-06-16 2023-06-15 4 ESPR Esperion Therapeutics, Inc.
Common Stock
A - Award 5,150 36,918 16.21
2022-05-27 2022-05-26 4 ESPR Esperion Therapeutics, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2022-02-07 2022-02-04 4 MRNS MARINUS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 12,375 12,375
2022-02-07 2022-02-04 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
A - Award 2,750 6,442 74.49
2021-05-28 2021-05-27 4 ESPR Esperion Therapeutics, Inc.
Common Stock
A - Award 12,376 31,768 63.82
2021-03-16 2021-03-16 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
J - Other 2,717 3,692 278.67
2021-03-16 2021-03-16 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
J - Other -11,612 0 -100.00
2021-03-16 2021-03-16 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
J - Other -6,192 0 -100.00
2021-03-16 2021-03-15 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
S - Sale -4,250 0 -100.00 15.87 -67,448
2021-03-16 2021-03-12 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
J - Other 6,192 6,192
2021-03-16 2021-03-12 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
J - Other -619,221 0 -100.00
2021-01-20 2021-01-15 4 MRNS MARINUS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 16,500 16,500
2020-11-06 2020-01-08 4/A MRNS MARINUS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 150,000 150,000
2020-05-29 2020-05-28 4 ESPR Esperion Therapeutics, Inc.
Common Stock
A - Award 6,106 19,392 45.96
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -42,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -30,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -30,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -30,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -25,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -25,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -20,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -20,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -50,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -25,159 0 -100.00 6.30 -158,502
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -3,393,382 0 -100.00 6.30 -21,378,307
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -36,431 0 -100.00 6.30 -229,515
2020-01-10 2020-01-08 4 MRNS MARINUS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 100,000 100,000
2019-08-08 2019-08-06 4 OBLN OBALON THERAPEUTICS INC
Warrants to Purchase Common Stock
P - Purchase 187,500 187,500 4.00 750,000 750,000
2019-08-08 2019-08-06 4 OBLN OBALON THERAPEUTICS INC
Common Stock
P - Purchase 250,000 813,433 44.37 4.00 1,000,000 3,253,732
2019-05-31 2019-05-29 4 ESPR Esperion Therapeutics, Inc.
Common Stock
A - Award 4,967 13,286 59.71
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
45,054
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
45,054
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
45,054
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
45,054
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
45,054
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
45,054
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
45,054
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
45,054
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
6,072,088
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
6,072,088
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
6,072,088
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
6,072,088
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
6,072,088
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
6,072,088
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
6,072,088
2019-05-13 3 ADYX Alliqua BioMedical, Inc.
Common Stock
6,072,088
2019-03-21 2019-03-21 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other 1,356 8,319 19.47
2019-03-21 2019-03-21 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other -17,790 0 -100.00
2019-03-21 2019-03-19 4 ESPR Esperion Therapeutics, Inc.
Common Stock
S - Sale -1,700 0 -100.00 45.25 -76,925
2019-03-21 2019-03-19 4 ESPR Esperion Therapeutics, Inc.
Common Stock
S - Sale -13,629 1,700 -88.91 44.66 -608,671 75,922
2019-03-21 2019-03-19 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other 17,790 17,790
2019-03-21 2019-03-19 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other -1,101,080 0 -100.00
2019-02-28 2019-02-26 4 MRNS MARINUS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 35,000 35,000
2019-01-25 2019-01-23 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 42,000 42,000
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Warrants to Purchase Common Stock
P - Purchase 15,000 15,000
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Series B Preferred Stock
C - Conversion -6,810,098 0 -100.00
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Convertible Promissory Note
C - Conversion 0
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Series D-1 Preferred Stock
C - Conversion -3,682,919 0 -100.00
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Series D Preferred Stock
C - Conversion -6,396,105 0 -100.00
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Series C Preferred Stock
C - Conversion -5,426,808 0 -100.00
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Series B-1 Preferred Stock
C - Conversion -2,986,762 0 -100.00
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Common Stock
P - Purchase 15,000 943,878 1.61 6.12 91,875 5,781,253
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Common Stock
C - Conversion 337,694 929,878 57.03 4.59 1,550,015 4,268,140
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Common Stock
C - Conversion 591,184 591,184
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Series B Preferred Stock
C - Conversion -50,532 0 -100.00
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Convertible Promissory Note
C - Conversion 0
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Series D-1 Preferred Stock
C - Conversion -27,328 0 -100.00
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Series D Preferred Stock
C - Conversion -47,460 0 -100.00
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Series C Preferred Stock
C - Conversion -40,268 0 -100.00
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Series B-1 Preferred Stock
C - Conversion -22,161 0 -100.00
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Common Stock
C - Conversion 2,505 6,891 57.11 4.59 11,498 31,630
2018-08-27 2018-08-23 4 BNGO BioNano Genomics, Inc
Common Stock
C - Conversion 4,386 4,386
2018-08-27 2018-08-23 4 OBLN OBALON THERAPEUTICS INC
Common Stock
P - Purchase 1,648,359 5,634,329 41.35 1.82 3,000,013 10,254,479
2018-08-21 3 BNGO BioNano Genomics, Inc
Common Stock
280
2018-08-21 3 BNGO BioNano Genomics, Inc
Common Stock
280
2018-08-21 3 BNGO BioNano Genomics, Inc
Common Stock
280
2018-08-21 3 BNGO BioNano Genomics, Inc
Common Stock
280
2018-08-21 3 BNGO BioNano Genomics, Inc
Common Stock
280
2018-08-21 3 BNGO BioNano Genomics, Inc
Common Stock
280
2018-08-21 3 BNGO BioNano Genomics, Inc
Common Stock
280
2018-08-21 3 BNGO BioNano Genomics, Inc
Common Stock
280
2018-06-26 2018-06-22 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other 3,846 6,963 123.39
2018-06-26 2018-06-22 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other -21,471 0 -100.00
2018-06-04 2018-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other 5,000 36,431 15.91
2018-06-04 2018-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other -25,000 0 -100.00
2018-05-25 2018-05-23 4 ESPR Esperion Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10,100 10,100
2018-02-13 2018-02-09 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 30,000 30,000
2018-01-26 2018-01-26 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other 645 3,177 25.47
2018-01-26 2018-01-26 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other -8,500 0 -100.00
2018-01-26 2018-01-25 4 ESPR Esperion Therapeutics, Inc.
Common Stock
S - Sale -11,674 15,329 -43.23 71.79 -838,076 1,100,469
2018-01-26 2018-01-24 4 ESPR Esperion Therapeutics, Inc.
Warrant to Purchase Common Stock
M - Exercise -1,193 0 -100.00
2018-01-26 2018-01-24 4 ESPR Esperion Therapeutics, Inc.
Warrant to Purchase Common Stock
M - Exercise -70,042 0 -100.00
2018-01-26 2018-01-24 4 ESPR Esperion Therapeutics, Inc.
Common Stock
F - Taxes -117 27,003 -0.43 71.82 -8,403 1,939,355
2018-01-26 2018-01-24 4 ESPR Esperion Therapeutics, Inc.
Common Stock
M - Exercise 1,193 27,120 4.60 6.99 8,339 189,569
2018-01-26 2018-01-24 4 ESPR Esperion Therapeutics, Inc.
Common Stock
F - Taxes -6,814 1,101,080 -0.62 71.82 -489,381 79,079,566
2018-01-26 2018-01-24 4 ESPR Esperion Therapeutics, Inc.
Common Stock
M - Exercise 70,042 1,107,894 6.75 6.99 489,594 7,744,179
2018-01-26 2018-01-24 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other 8,500 8,500
2018-01-26 2018-01-24 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other -850,000 1,037,852 -45.02
2018-01-24 2018-01-22 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
J - Other 2,250 46,450 5.09
2018-01-24 2018-01-22 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
J - Other -2,250 3,900 -36.59
2017-12-20 2017-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Redeemable Convertible Preferred Stock
C - Conversion -368 0 -100.00
2017-12-20 2017-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
A - Award 282 25,730 1.11
2017-12-20 2017-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
C - Conversion 12,444 25,448 95.69 3.19 39,696 81,179
2017-12-20 2017-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Redeemable Convertible Preferred Stock
C - Conversion -49,632 0 -100.00
2017-12-20 2017-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
A - Award 37,890 3,469,029 1.10
2017-12-20 2017-12-18 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
C - Conversion 1,678,432 3,431,139 95.76 3.19 5,354,198 10,945,333
2017-12-13 2017-12-11 4 OCRX Ocera Therapeutics, Inc.
Common Stock
D - Sale to Issuer -988,285 0 -100.00
2017-12-13 2017-12-11 4 OCRX Ocera Therapeutics, Inc.
Common Stock
D - Sale to Issuer -47,963 0 -100.00
2017-12-13 2017-12-11 4 OCRX Ocera Therapeutics, Inc.
Common Stock
D - Sale to Issuer -15,731 0 -100.00
2017-12-13 2017-12-11 4 OCRX Ocera Therapeutics, Inc.
Warrant to Purchase Common Stock
D - Sale to Issuer -20,150 0 -100.00
2017-12-13 2017-12-11 4 OCRX Ocera Therapeutics, Inc.
Warrant to Purchase Common Stock
D - Sale to Issuer -20,150 0 -100.00
2017-12-13 2017-12-11 4 OCRX Ocera Therapeutics, Inc.
Common Stock
D - Sale to Issuer -1,857,036 0 -100.00
2017-12-13 2017-12-11 4 OCRX Ocera Therapeutics, Inc.
Common Stock
D - Sale to Issuer -7,333 0 -100.00
2017-12-08 2017-12-08 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other 2,472 2,472
2017-12-08 2017-12-08 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other -32,560 0 -100.00
2017-12-08 2017-12-06 4 ESPR Esperion Therapeutics, Inc.
Common Stock
S - Sale -9,326 25,927 -26.45 53.85 -502,205 1,396,169
2017-12-08 2017-12-06 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other 3,291 32,560 11.24
2017-12-08 2017-12-06 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other -329,083 1,887,852 -14.84
2017-12-08 2017-12-06 4 MRNS MARINUS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 35,000 35,000
2017-09-11 2017-09-11 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
J - Other 1,650 44,200 3.88
2017-09-11 2017-09-11 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
J - Other -1,650 6,150 -21.15
2017-08-14 2017-08-10 4 ACHN ACHILLION PHARMACEUTICALS INC
Warrants to Purchase Common Stock
M - Exercise -20,706 0 -100.00
2017-08-14 2017-08-10 4 ACHN ACHILLION PHARMACEUTICALS INC
Warrants to Purchase Common Stock
M - Exercise -2,790,539 0 -100.00
2017-08-14 2017-08-10 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
F - Taxes -12,726 25,159 -33.59 5.06 -64,394 127,305
2017-08-14 2017-08-10 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
M - Exercise 20,706 37,885 120.53 3.11 64,447 117,917
2017-08-14 2017-08-10 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
F - Taxes -1,714,954 3,393,382 -33.57 5.06 -8,677,667 17,170,513
2017-08-14 2017-08-10 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
M - Exercise 2,790,539 5,108,336 120.40 3.11 8,685,553 15,899,696
2017-04-19 2017-04-17 4 ESPR Esperion Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 14,000 14,000
2017-04-12 2017-04-11 4 DRNA Dicerna Pharmaceuticals Inc
Redeemable Convertible Preferred Stock
P - Purchase 49,632 49,632 100.00 4,963,200 4,963,200
2017-04-12 2017-04-11 4 DRNA Dicerna Pharmaceuticals Inc
Redeemable Convertible Preferred Stock
P - Purchase 368 368 100.00 36,800 36,800
2017-01-19 2017-01-17 4 MRNS MARINUS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 10,500 10,500
2017-01-19 2017-01-17 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
A - Award 4,500 7,800 136.36
2017-01-19 2017-01-19 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 30,000 30,000
2016-11-04 2016-11-01 4 TBRA Tobira Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer 17,695 0 -100.00
2016-11-04 2016-11-01 4 TBRA Tobira Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer 1,071 0 -100.00
2016-11-04 2016-11-01 4 TBRA Tobira Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer 1,996 0 -100.00
2016-11-04 2016-11-01 4 TBRA Tobira Therapeutics, Inc.
Common Stock
U - Other -38,094 0 -100.00 28.35 -1,079,965
2016-11-03 2016-11-01 4 TBRA Tobira Therapeutics, Inc.
Common Stock
U - Other -3,553,322 0 -100.00 28.35 -100,736,679
2016-11-03 2016-11-01 4 TBRA Tobira Therapeutics, Inc.
Common Stock
U - Other -47,613 0 -100.00 28.35 -1,349,829
2016-11-03 2016-11-01 4 TBRA Tobira Therapeutics, Inc.
Common Stock
U - Other -1,657 0 -100.00 28.35 -46,976
2016-11-03 2016-11-01 4 TBRA Tobira Therapeutics, Inc.
Common Stock
U - Other -285,679 0 -100.00 28.35 -8,099,000
2016-10-14 2016-10-12 4 OBLN OBALON THERAPEUTICS INC
Series C Preferred Stock
C - Conversion -14,271 0 -100.00
2016-10-14 2016-10-12 4 OBLN OBALON THERAPEUTICS INC
Series B Preferred Stock
C - Conversion -20,583 0 -100.00
2016-10-14 2016-10-12 4 OBLN OBALON THERAPEUTICS INC
Series A Preferred Stock
C - Conversion -11,083 0 -100.00
2016-10-14 2016-10-12 4 OBLN OBALON THERAPEUTICS INC
Common Stock
C - Conversion 49,570 49,570
2016-10-14 2016-10-12 4 OBLN OBALON THERAPEUTICS INC
Series E Preferred Stock
C - Conversion -482,326 0 -100.00
2016-10-14 2016-10-12 4 OBLN OBALON THERAPEUTICS INC
Series D Preferred Stock
C - Conversion -597,207 0 -100.00
2016-10-14 2016-10-12 4 OBLN OBALON THERAPEUTICS INC
Series C Preferred Stock
C - Conversion -836,722 0 -100.00
2016-10-14 2016-10-12 4 OBLN OBALON THERAPEUTICS INC
Series B Preferred Stock
C - Conversion -1,206,836 0 -100.00
2016-10-14 2016-10-12 4 OBLN OBALON THERAPEUTICS INC
Series A Preferred Stock
C - Conversion -649,835 0 -100.00
2016-10-14 2016-10-12 4 OBLN OBALON THERAPEUTICS INC
Common Stock
C - Conversion 3,985,970 3,985,970
2016-09-13 2016-09-09 4 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
J - Other -1,943,109 0 -100.00
2016-08-05 2016-08-03 4 MRNS MARINUS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 7,700 7,700
2016-08-05 2016-08-03 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
A - Award 3,300 3,300
2016-08-03 2016-08-03 4 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
S - Sale -129 3,039 -4.07 8.15 -1,051 24,768
2016-08-03 2016-08-02 4 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
S - Sale -32 3,168 -1.00 8.71 -279 27,593
2016-08-03 2016-08-01 4 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
S - Sale -84 3,200 -2.56 8.82 -741 28,224
2016-08-03 2016-08-03 4 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
S - Sale -81,094 1,943,109 -4.01 8.15 -660,916 15,836,338
2016-08-03 2016-08-02 4 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
S - Sale -19,718 2,024,203 -0.96 8.71 -171,744 17,630,808
2016-08-03 2016-08-01 4 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
S - Sale -52,216 2,043,921 -2.49 8.82 -460,545 18,027,383
2016-07-12 2016-07-12 4 NONE Celator Pharmaceuticals Inc
Stock Option (Right to Buy)
D - Sale to Issuer -14,000 0 -100.00
2016-07-12 2016-07-12 4 NONE Celator Pharmaceuticals Inc
Stock Option (Right to Buy)
D - Sale to Issuer -14,000 0 -100.00
2016-07-12 2016-07-12 4 NONE Celator Pharmaceuticals Inc
Stock Option (Right to Buy)
D - Sale to Issuer -28,000 0 -100.00
2016-07-12 2016-07-12 4 NONE Celator Pharmaceuticals Inc
Warrant to Purchase Common Stock
D - Sale to Issuer -85,777 0 -100.00
2016-07-12 2016-07-12 4 NONE Celator Pharmaceuticals Inc
Warrant to Purchase Common Stock
D - Sale to Issuer -32,091 0 -100.00
2016-07-12 2016-07-12 4 NONE Celator Pharmaceuticals Inc
Warrant to Purchase Common Stock
D - Sale to Issuer -44,495 0 -100.00
2016-07-12 2016-07-12 4 NONE Celator Pharmaceuticals Inc
Common Stock
D - Sale to Issuer -5,867 0 -100.00 30.25 -177,477
2016-07-12 2016-07-12 4 NONE Celator Pharmaceuticals Inc
Common Stock
D - Sale to Issuer -16,733 0 -100.00 30.25 -506,173
2016-07-12 2016-07-12 4 NONE Celator Pharmaceuticals Inc
Common Stock
D - Sale to Issuer -2,378,924 0 -100.00 30.25 -71,962,451
2016-06-13 2016-06-09 4 ESPR Esperion Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 8,000 8,000
2016-05-27 2016-05-26 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -5,880 10,328 -36.28 4.70 -27,636 48,542
2016-05-27 2016-05-26 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -344,120 606,283 -36.21 4.70 -1,617,364 2,849,530
2016-05-02 2016-04-28 4 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
S - Sale -149,765 2,096,137 -6.67 6.96 -1,042,364 14,589,114
2016-05-02 2016-04-28 4 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
S - Sale -235 3,284 -6.68 6.96 -1,636 22,857
2016-04-27 2016-04-27 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -61 16,208 -0.37 5.02 -306 81,364
2016-04-27 2016-04-25 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -21 16,269 -0.13 5.20 -109 84,599
2016-04-27 2016-04-27 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -3,603 950,403 -0.38 5.02 -18,087 4,771,023
2016-04-27 2016-04-25 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -1,492 954,006 -0.16 5.20 -7,758 4,960,831
2016-04-21 2016-04-20 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -76 16,290 -0.46 5.29 -402 86,174
2016-04-21 2016-04-19 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -632 16,366 -3.72 5.36 -3,388 87,722
2016-04-21 2016-04-20 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -4,424 955,498 -0.46 5.29 -23,403 5,054,584
2016-04-21 2016-04-19 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -37,054 959,922 -3.72 5.36 -198,609 5,145,182
2016-04-13 2016-04-11 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -75 16,998 -0.44 5.22 -392 88,730
2016-04-13 2016-04-11 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -4,348 996,976 -0.43 5.22 -22,697 5,204,215
2016-04-08 2016-04-08 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -251 17,073 -1.45 5.35 -1,343 91,341
2016-04-08 2016-04-07 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -475 17,324 -2.67 5.26 -2,498 91,124
2016-04-08 2016-04-06 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -148 17,799 -0.82 5.22 -773 92,911
2016-04-08 2016-04-08 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -14,554 1,001,324 -1.43 5.35 -77,864 5,357,083
2016-04-08 2016-04-07 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -27,781 1,015,878 -2.66 5.26 -146,128 5,343,518
2016-04-08 2016-04-06 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -8,669 1,043,659 -0.82 5.22 -45,252 5,447,900
2016-03-08 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Series C-1 Preferred Stock
C - Conversion -360,640 0 -100.00
2016-03-08 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Series B-1 Preferred Stock
C - Conversion -400,422 0 -100.00
2016-03-08 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Common Stock
C - Conversion 761,062 761,062
2016-03-08 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Series C-1 Preferred Stock
C - Conversion -2,674 0 -100.00
2016-03-08 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Series B-1 Preferred Stock
C - Conversion -2,967 0 -100.00
2016-03-08 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Common Stock
C - Conversion 5,641 5,641
2016-03-08 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Series A-1 Preferred Stock
C - Conversion -13,925 0 -100.00
2016-03-08 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Common Stock
C - Conversion 13,925 13,925
2016-03-08 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Series B-1 Preferred Stock
C - Conversion -444,460 0 -100.00
2016-03-08 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Series A-1 Preferred Stock
C - Conversion -1,299,394 0 -100.00
2016-03-08 2016-03-08 4 SNDX Syndax Pharmaceuticals Inc
Common Stock
C - Conversion 1,743,854 1,743,854
2016-03-02 3 SNDX Syndax Pharmaceuticals Inc
Common Stock
27,128
2016-03-02 3 SNDX Syndax Pharmaceuticals Inc
Common Stock
27,128
2016-03-02 3 SNDX Syndax Pharmaceuticals Inc
Common Stock
27,128
2016-03-02 3 SNDX Syndax Pharmaceuticals Inc
Common Stock
27,128
2016-03-02 3 SNDX Syndax Pharmaceuticals Inc
Common Stock
27,128
2016-03-02 3 SNDX Syndax Pharmaceuticals Inc
Common Stock
27,128
2016-03-02 3 SNDX Syndax Pharmaceuticals Inc
Common Stock
27,128
2016-03-02 3 SNDX Syndax Pharmaceuticals Inc
Common Stock
27,128
2016-03-02 3 SNDX Syndax Pharmaceuticals Inc
Common Stock
27,128
2016-01-26 2016-01-25 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 30,000 30,000
2015-11-12 2015-11-11 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -370 17,179 -2.11 10.31 -3,815 177,115
2015-11-12 2015-11-11 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -49,630 2,317,797 -2.10 10.31 -511,685 23,896,487
2015-11-12 2015-11-10 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -1,325 17,549 -7.02 10.43 -13,820 183,036
2015-11-12 2015-11-10 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -177,749 2,367,427 -6.98 10.43 -1,853,922 24,692,264
2015-11-12 2015-11-09 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -2,375 18,874 -11.18 10.01 -23,774 188,929
2015-11-12 2015-11-09 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -318,551 2,545,176 -11.12 10.01 -3,188,696 25,477,212
2015-09-29 2015-09-25 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -69 21,249 -0.32 8.22 -567 174,667
2015-09-29 2015-09-25 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -9,241 2,863,727 -0.32 8.22 -75,961 23,539,836
2015-08-20 2015-08-18 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -11,836 1,052,328 -1.11 7.02 -83,089 7,387,343
2015-08-20 2015-08-18 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -202 17,947 -1.11 7.02 -1,418 125,988
2015-08-18 2015-08-18 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other 31,431 31,431
2015-08-18 2015-08-18 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other -483,521 0 -100.00
2015-08-18 2015-08-14 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -37,843 21,318 -63.97 7.51 -284,201 160,098
2015-07-22 2015-07-20 4 MRNS MARINUS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 6,300 6,300
2015-07-01 2015-06-30 4 GKOS GLAUKOS Corp
Series F Preferred Stock
C - Conversion -286,983 0 -100.00
2015-07-01 2015-06-30 4 GKOS GLAUKOS Corp
Series E Preferred Stock
C - Conversion -589,100 0 -100.00
2015-07-01 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 876,083 876,083
2015-07-01 2015-06-30 4 GKOS GLAUKOS Corp
Series F Preferred Stock
C - Conversion -2,130 0 -100.00
2015-07-01 2015-06-30 4 GKOS GLAUKOS Corp
Series E Preferred Stock
C - Conversion -4,371 0 -100.00
2015-07-01 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 6,501 6,501
2015-06-24 3 GKOS GLAUKOS Corp
Common Stock
126,400
2015-06-24 3 GKOS GLAUKOS Corp
Common Stock
126,400
2015-06-24 3 GKOS GLAUKOS Corp
Common Stock
126,400
2015-06-24 3 GKOS GLAUKOS Corp
Common Stock
126,400
2015-06-24 3 GKOS GLAUKOS Corp
Common Stock
126,400
2015-06-24 3 GKOS GLAUKOS Corp
Common Stock
126,400
2015-06-24 3 GKOS GLAUKOS Corp
Common Stock
126,400
2015-06-24 3 GKOS GLAUKOS Corp
Common Stock
126,400
2015-06-24 3 GKOS GLAUKOS Corp
Common Stock
126,400
2015-06-12 2015-06-11 4 NONE Celator Pharmaceuticals Inc
Stock Option (Right to Buy)
A - Award 14,000 14,000
2015-05-22 2015-05-21 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other 222,630 483,521 85.33
2015-05-22 2015-05-21 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other -1,700,000 2,872,968 -37.17
2015-05-15 2015-05-14 4 ESPR Esperion Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 8,000 8,000
2015-05-12 2015-05-12 4 LIFE aTYR PHARMA INC
Series E Preferred Stock
C - Conversion -887,073 0 -100.00
2015-05-12 2015-05-12 4 LIFE aTYR PHARMA INC
Series D Preferred Stock
C - Conversion -1,506,901 0 -100.00
2015-05-12 2015-05-12 4 LIFE aTYR PHARMA INC
Series C Preferred Stock
C - Conversion -12,143,933 0 -100.00
2015-05-12 2015-05-12 4 LIFE aTYR PHARMA INC
Common Stock
C - Conversion 1,807,820 1,807,820
2015-05-12 2015-05-12 4 LIFE aTYR PHARMA INC
Series E Preferred Stock
C - Conversion -6,581 0 -100.00
2015-05-12 2015-05-12 4 LIFE aTYR PHARMA INC
Series D Preferred Stock
C - Conversion -11,182 0 -100.00
2015-05-12 2015-05-12 4 LIFE aTYR PHARMA INC
Series C Preferred Stock
C - Conversion -90,110 0 -100.00
2015-05-12 2015-05-12 4 LIFE aTYR PHARMA INC
Common Stock
C - Conversion 13,414 13,414
2015-05-11 2015-05-11 4 CLCD CoLucid Pharmaceuticals, Inc.
Series B Preferred Stock
C - Conversion -1,565 0 -100.00
2015-05-11 2015-05-11 4 CLCD CoLucid Pharmaceuticals, Inc.
Series A Preferred Stock
C - Conversion -1,954 0 -100.00
2015-05-11 2015-05-11 4 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
C - Conversion 3,519 3,519
2015-05-11 2015-05-11 4 CLCD CoLucid Pharmaceuticals, Inc.
Series C Preferred Stock
C - Conversion -464,756 0 -100.00
2015-05-11 2015-05-11 4 CLCD CoLucid Pharmaceuticals, Inc.
Series B Preferred Stock
C - Conversion -939,289 0 -100.00
2015-05-11 2015-05-11 4 CLCD CoLucid Pharmaceuticals, Inc.
Series A Preferred Stock
C - Conversion -798,188 0 -100.00
2015-05-11 2015-05-11 4 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
C - Conversion 2,202,233 2,245,902 5,043.01
2015-05-06 2015-05-04 4 TBRA Tibira Therapeutics, Inc.
Common Stock
J - Other 36,187 38,094 1,897.59
2015-05-06 2015-05-04 4 TBRA Regado Biosciences Inc
Common Stock
P - Purchase 277,777 3,553,322 8.48 10.62 2,949,992 37,736,280
2015-05-06 3 TBRA Regado Biosciences Inc
Common Stock
6,551,090
2015-05-06 3 TBRA Regado Biosciences Inc
Common Stock
6,551,090
2015-05-06 3 TBRA Regado Biosciences Inc
Common Stock
6,551,090
2015-05-06 3 TBRA Regado Biosciences Inc
Common Stock
6,551,090
2015-05-06 3 TBRA Regado Biosciences Inc
Common Stock
6,551,090
2015-05-06 3 TBRA Regado Biosciences Inc
Common Stock
6,551,090
2015-05-06 3 TBRA Regado Biosciences Inc
Common Stock
6,551,090
2015-05-06 3 TBRA Regado Biosciences Inc
Common Stock
6,551,090
2015-05-06 3 TBRA Tibira Therapeutics, Inc.
Common Stock
95,226
2015-05-06 3 TBRA Tibira Therapeutics, Inc.
Common Stock
95,226
2015-05-06 3 TBRA Tibira Therapeutics, Inc.
Common Stock
95,226
2015-05-06 3 TBRA Tibira Therapeutics, Inc.
Common Stock
95,226
2015-05-06 3 TBRA Tibira Therapeutics, Inc.
Common Stock
95,226
2015-05-06 3 TBRA Tibira Therapeutics, Inc.
Common Stock
95,226
2015-05-06 3 TBRA Tibira Therapeutics, Inc.
Common Stock
95,226
2015-05-06 3 TBRA Tibira Therapeutics, Inc.
Common Stock
95,226
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-06 3 LIFE aTYR PHARMA INC
Common Stock
18,858
2015-05-05 3 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
87,338
2015-05-05 3 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
87,338
2015-05-05 3 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
87,338
2015-05-05 3 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
87,338
2015-05-05 3 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
87,338
2015-05-05 3 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
87,338
2015-05-05 3 CLCD CoLucid Pharmaceuticals, Inc.
Common Stock
87,338
2015-04-16 2015-04-16 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -32,411 1,064,164 -2.96 7.07 -229,146 7,523,639
2015-04-16 2015-04-15 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -7,920 1,096,575 -0.72 7.58 -60,034 8,312,038
2015-04-16 2015-04-14 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -9,832 1,104,495 -0.88 7.78 -76,493 8,592,971
2015-04-16 2015-04-16 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -554 18,149 -2.96 7.07 -3,917 128,313
2015-04-16 2015-04-15 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -135 18,703 -0.72 7.58 -1,023 141,769
2015-04-16 2015-04-14 4 EVOK Evoke Pharma Inc
Common Stock
S - Sale -168 18,838 -0.88 7.78 -1,307 146,560
2015-03-24 2015-03-20 4 ESPR Esperion Therapeutics, Inc.
Common Stock
J - Other -350,000 2,216,935 -13.63
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Series C Preferred Stock Warrant (Right to Buy)
M - Exercise -2,827 0 -100.00
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Series B-2 Preferred Stock Warrant (Right to Buy)
M - Exercise -1,570 0 -100.00
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Series C Preferred Stock
C - Conversion -102,282 0 -100.00
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Series B-2 Preferred Stock
C - Conversion -36,913 0 -100.00
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Series B Preferred Stock
C - Conversion -104,247 0 -100.00
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Series A Preferred Stock
C - Conversion -12,578 0 -100.00
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Common Stock
F - Taxes -1,725 48,025 -3.47 14.00 -24,150 672,350
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Common Stock
M - Exercise 2,827 49,750 6.02 8.54 24,143 424,865
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Common Stock
F - Taxes -958 46,923 -2.00 14.00 -13,412 656,922
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Common Stock
M - Exercise 1,570 47,881 3.39 8.54 13,408 408,904
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Common Stock
C - Conversion 46,311 46,311
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Series C Preferred Stock Warrant (Right to Buy)
M - Exercise -165,790 0 -100.00
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Series B-2 Preferred Stock Warrant (Right to Buy)
M - Exercise -92,105 0 -100.00
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Series C Preferred Stock
C - Conversion -7,252,144 0 -100.00
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Series B-2 Preferred Stock
C - Conversion -2,164,305 0 -100.00
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Series B Preferred Stock
C - Conversion -6,111,968 0 -100.00
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Series A Preferred Stock
C - Conversion -737,422 0 -100.00
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Common Stock
P - Purchase 70,000 3,091,643 2.32 14.00 980,000 43,283,002
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Common Stock
F - Taxes -101,132 3,021,643 -3.24 14.00 -1,415,848 42,303,002
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Common Stock
M - Exercise 165,790 3,122,775 5.61 8.54 1,415,847 26,668,498
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Common Stock
F - Taxes -56,185 2,956,985 -1.86 14.00 -786,590 41,397,790
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Common Stock
M - Exercise 92,105 3,013,170 3.15 8.54 786,577 25,732,472
2014-12-10 2014-11-25 4/A NEOT Neothetics, Inc.
Common Stock
C - Conversion 2,921,065 2,921,065
2014-12-04 2014-12-02 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 25,000 25,000
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Series C Preferred Stock Warrant (Right to Buy)
M - Exercise -165,790 0 -100.00
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Series B-2 Preferred Stock Warrant (Right to Buy)
M - Exercise -92,105 0 -100.00
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Series C Preferred Stock
C - Conversion -7,252,144 0 -100.00
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Series B-2 Preferred Stock
C - Conversion -2,164,305 0 -100.00
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Series B Preferred Stock
C - Conversion -6,111,968 0 -100.00
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Series A Preferred Stock
C - Conversion -737,422 0 -100.00
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Common Stock
P - Purchase 70,000 3,091,642 2.32 14.00 980,000 43,282,988
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Common Stock
F - Taxes -101,132 3,021,642 -3.24 14.00 -1,415,848 42,302,988
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Common Stock
M - Exercise 165,790 3,122,774 5.61 8.54 1,415,847 26,668,490
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Common Stock
F - Taxes -56,185 2,956,984 -1.86 14.00 -786,590 41,397,776
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Common Stock
M - Exercise 92,105 3,013,169 3.15 8.54 786,577 25,732,463
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Common Stock
C - Conversion 2,921,064 2,921,064
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Series C Preferred Stock Warrant (Right to Buy)
M - Exercise -2,827 0 -100.00
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Series B-2 Preferred Stock Warrant (Right to Buy)
M - Exercise -1,570 0 -100.00
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Series C Preferred Stock
C - Conversion -102,282 0 -100.00
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Series B-2 Preferred Stock
C - Conversion -36,913 0 -100.00
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Series B Preferred Stock
C - Conversion -104,247 0 -100.00
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Series A Preferred Stock
C - Conversion -12,578 0 -100.00
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Common Stock
F - Taxes -1,725 48,023 -3.47 14.00 -24,150 672,322
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Common Stock
M - Exercise 2,827 49,748 6.03 8.54 24,143 424,848
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Common Stock
F - Taxes -958 46,921 -2.00 14.00 -13,412 656,894
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Common Stock
M - Exercise 1,570 47,879 3.39 8.54 13,408 408,887
2014-11-26 2014-11-25 4 NEOT Neothetics, Inc.
Common Stock
C - Conversion 46,309 46,309
2014-11-19 3 NEOT Neothetics, Inc.
Common Stock
7,868
2014-11-19 3 NEOT Neothetics, Inc.
Common Stock
7,868
2014-11-19 3 NEOT Neothetics, Inc.
Common Stock
7,868
2014-11-19 3 NEOT Neothetics, Inc.
Common Stock
7,868
2014-11-19 3 NEOT Neothetics, Inc.
Common Stock
7,868
2014-11-19 3 NEOT Neothetics, Inc.
Common Stock
7,868
2014-11-19 3 NEOT Neothetics, Inc.
Common Stock
7,868
2014-11-19 3 NEOT Neothetics, Inc.
Common Stock
7,868
2014-11-19 3 NEOT Neothetics, Inc.
Common Stock
7,868
2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Common Stock
D - Sale to Issuer -6,250 0 -100.00
2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -8,575 0 -100.00
2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Common Stock
D - Sale to Issuer -22,306 0 -100.00
2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Common Stock
D - Sale to Issuer -3,006,132 0 -100.00
2014-10-21 2014-10-21 4 ESPR Esperion Therapeutics, Inc.
Common Stock
P - Purchase 500,000 2,566,935 24.19 20.00 10,000,000 51,338,700
2014-10-21 2014-10-21 4 ATRA Atara Biotherapeutics, Inc.
Series B Preferred Stock
C - Conversion -4,606 0 -100.00
2014-10-21 2014-10-21 4 ATRA Atara Biotherapeutics, Inc.
Series A Preferred Stock
C - Conversion -9,443 0 -100.00
2014-10-21 2014-10-21 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
P - Purchase 1,841 15,890 13.10 11.00 20,251 174,790
2014-10-21 2014-10-21 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
C - Conversion 14,049 14,049
2014-10-21 2014-10-21 4 ATRA Atara Biotherapeutics, Inc.
Series B Preferred Stock
C - Conversion -620,776 0 -100.00
2014-10-21 2014-10-21 4 ATRA Atara Biotherapeutics, Inc.
Series A Preferred Stock
C - Conversion -1,272,607 0 -100.00
2014-10-21 2014-10-21 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
P - Purchase 248,159 2,141,542 13.11 11.00 2,729,749 23,556,962
2014-10-21 2014-10-21 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
C - Conversion 1,893,383 1,893,383
2014-10-01 2014-09-30 4 MRNS MARINUS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 6,000 6,000
2014-09-12 2014-09-10 4 VCYT VERACYTE, INC.
Common Stock
J - Other -300,000 2,763,294 -9.79
2014-09-11 2014-09-09 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other 100,995 260,891 63.16
2014-09-11 2014-09-09 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other -1,200,000 4,572,968 -20.79
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Series C Preferred Stock Warrant (Right to Buy)
M - Exercise -502 0 -100.00
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Series D Preferred Stock
F - Taxes -1,386 0 -100.00
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Series C Preferred Stock
C - Conversion -6,866 0 -100.00
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Series B Preferred Stock
C - Conversion -3,238 0 -100.00
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock
F - Taxes -277 11,715 -2.31 16.00 -4,432 187,440
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock
M - Exercise 502 11,992 4.37 8.79 4,413 105,410
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock
C - Conversion 11,490 11,490
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Series C Preferred Stock Warrant (Right to Buy)
M - Exercise -67,755 0 -100.00
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Series D Preferred Stock
F - Taxes -186,828 0 -100.00
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Series C Preferred Stock
C - Conversion -925,479 0 -100.00
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Series B Preferred Stock
C - Conversion -436,485 0 -100.00
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock
F - Taxes -37,224 1,579,323 -2.30 16.00 -595,584 25,269,168
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock
M - Exercise 67,755 1,616,547 4.37 8.79 595,566 14,209,448
2014-08-18 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock
C - Conversion 1,548,792 1,548,792
2014-08-07 2014-08-05 4 MRNS MARINUS PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -1,165 0 -100.00
2014-08-07 2014-08-05 4 MRNS MARINUS PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -7,043 0 -100.00
2014-08-07 2014-08-05 4 MRNS MARINUS PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -8,792 0 -100.00
2014-08-07 2014-08-05 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
C - Conversion 17,000 17,000
2014-08-07 2014-08-05 4 MRNS MARINUS PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -579,630 0 -100.00
2014-08-07 2014-08-05 4 MRNS MARINUS PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -657,192 0 -100.00
2014-08-07 2014-08-05 4 MRNS MARINUS PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -820,320 0 -100.00
2014-08-07 2014-08-05 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
P - Purchase 419,744 2,476,886 20.40 8.00 3,357,952 19,815,088
2014-08-07 2014-08-05 4 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
C - Conversion 2,057,142 2,057,142
2014-07-31 3 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
85,100
2014-07-31 3 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
85,100
2014-07-31 3 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
85,100
2014-07-31 3 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
85,100
2014-07-31 3 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
85,100
2014-07-31 3 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
85,100
2014-07-31 3 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
85,100
2014-07-31 3 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
85,100
2014-07-31 3 MRNS MARINUS PHARMACEUTICALS INC
Common Stock
85,100
2014-06-13 2014-06-12 4 NONE Celator Pharmaceuticals Inc
Stock Option (Right to Buy)
A - Award 14,000 14,000
2014-05-22 2014-05-21 4 DRTX Durata Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 8,575 8,575
2014-05-16 2014-05-15 4 ESPR Esperion Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 5,000 5,000
2014-05-07 2014-05-07 4 ALDX Aldeyra Therapeutics, Inc.
Convertible Promissory Note
C - Conversion 0
2014-05-07 2014-05-07 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock
C - Conversion 21,250 1,973,389 1.09
2014-05-05 2014-05-01 4 ALDX Aldeyra Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -3,882 0 -100.00
2014-05-05 2014-05-01 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock
C - Conversion 9,208 9,208
2014-05-05 2014-05-01 4 ALDX Aldeyra Therapeutics, Inc.
Series B Preferred Stock Warrant (Right to Buy)
M - Exercise -60,576 0 -100.00
2014-05-05 2014-05-01 4 ALDX Aldeyra Therapeutics, Inc.
Series B Preferred Stock Warrant (Right to Buy)
M - Exercise -60,576 0 -100.00
2014-05-05 2014-05-01 4 ALDX Aldeyra Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -755,263 0 -100.00
2014-05-05 2014-05-01 4 ALDX Aldeyra Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -486,316 0 -100.00
2014-05-05 2014-05-01 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock
F - Taxes -39,063 1,952,139 -1.96 8.00 -312,504 15,617,112
2014-05-05 2014-05-01 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock
F - Taxes -39,063 1,952,139 -1.96 8.00 -312,504 15,617,112
2014-05-05 2014-05-01 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock
M - Exercise 60,576 1,991,202 3.14 5.16 312,572 10,274,602
2014-05-05 2014-05-01 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock
M - Exercise 60,576 1,991,202 3.14 5.16 312,572 10,274,602
2014-05-05 2014-05-01 4 ALDX Aldeyra Therapeutics, Inc.
Common Stock
C - Conversion 1,909,113 1,909,113
2014-05-01 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock
20,716
2014-05-01 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock
20,716
2014-05-01 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock
20,716
2014-05-01 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock
20,716
2014-05-01 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock
20,716
2014-05-01 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock
20,716
2014-05-01 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock
20,716
2014-05-01 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock
20,716
2014-05-01 3 ALDX Aldeyra Therapeutics, Inc.
Common Stock
20,716
2014-03-21 2014-03-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -27,500 0 -100.00 14.00 -385,000
2014-03-21 2014-03-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -78,369 0 -100.00 14.00 -1,097,166
2014-03-21 2014-03-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -7,313,241 0 -100.00 14.00 -102,385,374
2014-03-21 2014-03-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -50,743 0 -100.00 14.00 -710,402
2014-03-21 2014-03-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -2,972,678 0 -100.00 14.00 -41,617,492
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Series D Preferred Stock
C - Conversion -7,430 0 -100.00
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Series C Preferred Stock
C - Conversion -15,799 0 -100.00
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Series B Preferred Stock
C - Conversion -10,661 0 -100.00
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Series D Preferred Stock
C - Conversion -435,663 0 -100.00
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Series C Preferred Stock
C - Conversion -926,321 0 -100.00
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Series B Preferred Stock
C - Conversion -625,065 0 -100.00
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Common Stock
C - Conversion 33,890 33,890
2014-03-17 2014-03-17 4 AKAO Achaogen Inc
Common Stock
C - Conversion 1,987,049 1,987,049
2014-02-14 2014-02-12 4 CADX CADENCE PHARMACEUTICALS INC
Warrants to Purchase Common Stock
M - Exercise -1,367,020 0 -100.00
2014-02-14 2014-02-12 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
F - Taxes -765,532 2,972,678 -20.48 14.00 -10,717,448 41,617,492
2014-02-14 2014-02-12 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
M - Exercise 1,367,020 3,738,210 57.65 7.84 10,717,437 29,307,566
2014-02-14 2014-02-12 4 CADX CADENCE PHARMACEUTICALS INC
Warrants to Purchase Common Stock
M - Exercise -23,317 0 -100.00
2014-02-14 2014-02-12 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
F - Taxes -13,058 50,743 -20.47 14.00 -182,812 710,402
2014-02-14 2014-02-12 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
M - Exercise 23,317 63,801 57.60 7.84 182,805 500,200
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Warrant
C - Conversion 156 156
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Warrant
C - Conversion -156 0 -100.00
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Series C Preferred Stock
C - Conversion -9,469 0 -100.00
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Series B Preferred Stock
C - Conversion -3,535 0 -100.00
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Warrant
C - Conversion 21,041 21,041
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Warrant
C - Conversion -21,041 0 -100.00
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Series C Preferred Stock
C - Conversion -1,276,243 0 -100.00
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Series B Preferred Stock
C - Conversion -476,464 0 -100.00
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
C - Conversion 13,004 13,004
2014-02-04 2014-02-04 4 DRNA Dicerna Pharmaceuticals Inc
Common Stock
C - Conversion 1,752,707 1,752,707
2014-01-17 2014-01-16 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -2,230 34,907 -6.00 6.56 -14,629 228,990
2014-01-17 2014-01-15 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -1,010 37,137 -2.65 6.01 -6,070 223,193
2014-01-17 2014-01-16 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -204,315 3,590,931 -5.38 6.56 -1,340,306 23,556,507
2014-01-17 2014-01-15 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -92,445 3,795,246 -2.38 6.01 -555,594 22,809,428
2013-12-19 2013-12-17 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 25,000 25,000
2013-11-19 2013-11-19 4 TNDM TANDEM DIABETES CARE INC
Warrant to Purchase Common Stock
J - Other 6,008 6,008
2013-11-19 2013-11-19 4 TNDM TANDEM DIABETES CARE INC
Warrant to Purchase Series D Preferred Stock
J - Other -10,068 0 -100.00
2013-11-19 2013-11-19 4 TNDM TANDEM DIABETES CARE INC
Series D Preferred Stock
C - Conversion -38,941 0 -100.00
2013-11-19 2013-11-19 4 TNDM TANDEM DIABETES CARE INC
Series C Preferred Stock
C - Conversion -9,378 0 -100.00
2013-11-19 2013-11-19 4 TNDM TANDEM DIABETES CARE INC
Series B Preferred Stock
C - Conversion -6,071 0 -100.00
2013-11-19 2013-11-19 4 TNDM TANDEM DIABETES CARE INC
Warrant to Purchase Common Stock
J - Other 352,351 352,351
2013-11-19 2013-11-19 4 TNDM TANDEM DIABETES CARE INC
Warrant to Purchase Series D Preferred Stock
J - Other -590,403 0 -100.00
2013-11-19 2013-11-19 4 TNDM TANDEM DIABETES CARE INC
Series D Preferred Stock
C - Conversion -2,283,114 0 -100.00
2013-11-19 2013-11-19 4 TNDM TANDEM DIABETES CARE INC
Series C Preferred Stock
C - Conversion -549,833 0 -100.00
2013-11-19 2013-11-19 4 TNDM TANDEM DIABETES CARE INC
Series B Preferred Stock
C - Conversion -356,111 0 -100.00
2013-11-19 2013-11-19 4 TNDM TANDEM DIABETES CARE INC
Common Stock
C - Conversion 54,390 54,390
2013-11-19 2013-11-19 4 TNDM TANDEM DIABETES CARE INC
Common Stock
C - Conversion 3,189,058 3,189,058
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Series C Preferred Stock
C - Conversion -5,053 0 -100.00
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Series C Preferred Stock
C - Conversion -680,972 0 -100.00
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Series B Preferred Stock
C - Conversion -17,677 0 -100.00
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Series B Preferred Stock
C - Conversion -2,382,322 0 -100.00
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Common Stock
C - Conversion 22,730 22,730
2013-11-04 2013-11-04 4 VCYT VERACYTE, INC.
Common Stock
C - Conversion 3,063,294 3,063,294
2013-09-30 2013-09-30 4 EVOK Evoke Pharma Inc
Series A Preferred Stock
C - Conversion -19,006 0 -100.00
2013-09-30 2013-09-30 4 EVOK Evoke Pharma Inc
Series A Preferred Stock
C - Conversion -1,114,327 0 -100.00
2013-09-30 2013-09-30 4 EVOK Evoke Pharma Inc
Common Stock
C - Conversion 19,006 19,006
2013-09-30 2013-09-30 4 EVOK Evoke Pharma Inc
Common Stock
C - Conversion 1,114,327 1,114,327
2013-09-24 3 EVOK Evoke Pharma Inc
Common Stock
5,250
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Series D Preferred Stock
C - Conversion -7,407 0 -100.00
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Series C Preferred Stock
C - Conversion -2,899 0 -100.00
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Series B Preferred Stock
C - Conversion -4,233 0 -100.00
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Series E Preferred Stock
C - Conversion -225,913 0 -100.00
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Series D Preferred Stock
C - Conversion -894,120 0 -100.00
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Series C Preferred Stock
C - Conversion -270,568 0 -100.00
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Series B Preferred Stock
C - Conversion -394,969 0 -100.00
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Common Stock
C - Conversion 7,407 14,920 98.59
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Common Stock
C - Conversion 2,899 7,513 62.83
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Common Stock
C - Conversion 4,233 4,614 1,111.02
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Common Stock
P - Purchase 750,000 2,571,117 41.18 4.00 3,000,000 10,284,468
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Common Stock
C - Conversion 225,913 1,821,117 14.16
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Common Stock
C - Conversion 894,120 1,595,204 127.53
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Common Stock
C - Conversion 270,568 701,084 62.85
2013-08-28 2013-08-27 4 RGDO Regado Biosciences Inc
Common Stock
C - Conversion 394,969 430,516 1,111.12
2013-08-21 3 RGDO Regado Biosciences Inc
Common Stock
35,547
2013-08-21 3 RGDO Regado Biosciences Inc
Common Stock
381
2013-08-21 3 RGDO Regado Biosciences Inc
Common Stock
17,171
2013-07-31 2013-07-15 4/A OCRX Ocera Therapeutics, Inc.
Common Stock
P - Purchase 331,873 1,857,036 21.76 6.03 1,999,999 11,191,242
2013-07-31 2013-07-15 4/A OCRX Ocera Therapeutics, Inc.
Common Stock
P - Purchase 7,333 7,333 6.03 44,192 44,192
2013-07-31 2013-07-15 4/A OCRX Ocera Therapeutics, Inc.
Common Stock
P - Purchase 988,285 988,285 6.03 5,955,801 5,955,801
2013-07-31 3/A OCRX Ocera Therapeutics, Inc.
Common Stock
47,963
2013-07-31 3/A OCRX Ocera Therapeutics, Inc.
Common Stock
1,525,163
2013-07-31 3/A OCRX Ocera Therapeutics, Inc.
Common Stock
15,731
2013-07-16 2013-07-15 4 OCRX Ocera Therapeutics, Inc.
Common Stock
P - Purchase 331,873 1,897,336 21.20 6.03 1,999,999 11,434,106
2013-07-16 2013-07-15 4 OCRX Ocera Therapeutics, Inc.
Common Stock
P - Purchase 7,333 7,333 6.03 44,192 44,192
2013-07-16 2013-07-15 4 OCRX Ocera Therapeutics, Inc.
Common Stock
P - Purchase 988,285 988,285 6.03 5,955,801 5,955,801
2013-07-16 3 OCRX Ocera Therapeutics, Inc.
Common Stock
47,963
2013-07-16 3 OCRX Ocera Therapeutics, Inc.
Common Stock
1,565,463
2013-07-16 3 OCRX Ocera Therapeutics, Inc.
Common Stock
15,731
2013-07-02 2013-07-01 4 ESPR Esperion Therapeutics, Inc.
Warrant to Purchase Common Stock
J - Other 1,193 1,193
2013-07-02 2013-07-01 4 ESPR Esperion Therapeutics, Inc.
Warrant to Purchase Series A Preferred Stock
J - Other -8,346 0 -100.00
2013-07-02 2013-07-01 4 ESPR Esperion Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -30,462 0 -100.00
2013-07-02 2013-07-01 4 ESPR Esperion Therapeutics, Inc.
Warrant to Purchase Common Stock
J - Other 70,042 70,042
2013-07-02 2013-07-01 4 ESPR Esperion Therapeutics, Inc.
Warrant to Purchase Series A Preferred Stock
J - Other -489,320 0 -100.00
2013-07-02 2013-07-01 4 ESPR Esperion Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -1,786,012 0 -100.00
2013-07-02 2013-07-01 4 ESPR Esperion Therapeutics, Inc.
Common Stock
P - Purchase 4,791 35,253 15.73 14.00 67,074 493,542
2013-07-02 2013-07-01 4 ESPR Esperion Therapeutics, Inc.
Common Stock
C - Conversion 30,462 30,462
2013-07-02 2013-07-01 4 ESPR Esperion Therapeutics, Inc.
Common Stock
P - Purchase 280,923 2,066,935 15.73 14.00 3,932,922 28,937,090
2013-07-02 2013-07-01 4 ESPR Esperion Therapeutics, Inc.
Common Stock
C - Conversion 1,786,012 1,786,012
2013-06-25 3 ESPR Esperion Therapeutics, Inc.
Common Stock
21,471
2013-06-24 2013-06-20 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -114 38,147 -0.30 5.01 -571 191,116
2013-06-24 2013-06-20 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -10,516 3,887,691 -0.27 5.01 -52,685 19,477,332
2013-06-20 2013-06-19 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -22,423 3,898,207 -0.57 5.37 -120,412 20,933,372
2013-06-20 2013-06-18 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -32,855 3,920,630 -0.83 5.40 -177,417 21,171,402
2013-06-20 2013-06-19 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -244 38,261 -0.63 5.37 -1,310 205,462
2013-06-20 2013-06-18 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -359 38,505 -0.92 5.40 -1,939 207,927
2013-06-18 2013-06-17 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -959 38,864 -2.41 5.40 -5,179 209,866
2013-06-18 2013-06-14 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -425 39,823 -1.06 5.03 -2,138 200,310
2013-06-18 2013-06-17 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -87,812 3,953,485 -2.17 5.40 -474,185 21,348,819
2013-06-18 2013-06-14 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -38,897 4,041,297 -0.95 5.03 -195,652 20,327,724
2013-06-13 2013-06-11 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -59 40,248 -0.15 5.00 -295 201,240
2013-06-13 2013-06-11 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale X -5,337 4,080,194 -0.13 5.00 -26,685 20,400,970
2013-06-05 2013-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -159,192 2,581,745 -5.81 64.58 -10,280,619 166,729,092
2013-06-05 2013-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,779 44,034 -5.94 64.58 -179,468 2,843,716
2013-06-04 2013-06-03 4 NONE Celator Pharmaceuticals Inc
Stock Option (Right to Buy)
A - Award 28,000 28,000
2013-05-17 2013-05-16 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale -232 40,307 -0.57 4.50 -1,044 181,382
2013-05-17 2013-05-15 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale -251 40,539 -0.62 4.70 -1,180 190,533
2013-05-17 2013-05-16 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale -21,276 4,085,531 -0.52 4.50 -95,742 18,384,890
2013-05-17 2013-05-15 4 ALIM ALIMERA SCIENCES INC
Common Stock
S - Sale -22,966 4,106,807 -0.56 4.70 -107,940 19,301,993
2013-05-01 2013-04-29 4 NONE Celator Pharmaceuticals Inc
Warrant to Purchase Common Stock
J - Other 85,777 85,777
2013-05-01 2013-04-29 4 NONE Celator Pharmaceuticals Inc
Warrant to Purchase Common Stock
J - Other 12,906 32,091 67.27
2013-05-01 2013-04-29 4 NONE Celator Pharmaceuticals Inc
Warrant to Purchase Common Stock
J - Other 17,895 44,495 67.27
2013-05-01 2013-04-29 4 NONE Celator Pharmaceuticals Inc
Common Stock
J - Other 156,749 2,378,924 7.05
2013-04-17 2013-04-15 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -23,210 2,371,190 -0.97 6.62 -153,650 15,697,278
2013-04-17 2013-04-15 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -71,578 7,313,241 -0.97 6.62 -473,846 48,413,655
2013-04-10 2013-04-10 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -1,567 2,394,400 -0.07 6.72 -10,530 16,090,368
2013-04-10 2013-04-09 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -11,386 2,395,967 -0.47 6.71 -76,400 16,076,939
2013-04-10 2013-04-08 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -12,217 2,407,353 -0.50 6.52 -79,655 15,695,942
2013-04-10 2013-04-10 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -4,832 7,384,819 -0.07 6.72 -32,471 49,625,984
2013-04-10 2013-04-09 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -35,114 7,389,651 -0.47 6.71 -235,615 49,584,558
2013-04-10 2013-04-08 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -37,676 7,424,765 -0.50 6.52 -245,648 48,409,468
2013-03-22 2013-03-21 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -4,374 2,419,570 -0.18 5.35 -23,401 12,944,700
2013-03-22 2013-03-21 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -893 40,484 -2.16 5.49 -4,903 222,257
2013-03-22 2013-03-21 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -13,490 7,462,441 -0.18 5.35 -72,172 39,924,059
2013-03-22 2013-03-21 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -1,743 78,369 -2.18 5.49 -9,569 430,246
2013-03-21 2013-03-20 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -5,510 2,423,944 -0.23 5.22 -28,762 12,652,988
2013-03-21 2013-03-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -7,925 2,429,454 -0.33 5.19 -41,131 12,608,866
2013-03-21 2013-03-20 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -92 41,377 -0.22 5.22 -480 215,988
2013-03-21 2013-03-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -134 41,469 -0.32 5.19 -695 215,224
2013-03-21 2013-03-20 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -182 80,112 -0.23 5.22 -950 418,185
2013-03-21 2013-03-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -261 80,294 -0.32 5.19 -1,355 416,726
2013-03-21 2013-03-20 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -16,995 7,475,931 -0.23 5.22 -88,714 39,024,360
2013-03-21 2013-03-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -24,442 7,492,926 -0.33 5.19 -126,854 38,888,286
2013-03-19 2013-03-18 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -8,020 2,437,379 -0.33 5.16 -41,383 12,576,876
2013-03-19 2013-03-15 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -9,636 2,445,399 -0.39 5.28 -50,878 12,911,707
2013-03-19 2013-03-18 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -135 41,603 -0.32 5.16 -697 214,671
2013-03-19 2013-03-15 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -163 41,738 -0.39 5.28 -861 220,377
2013-03-19 2013-03-18 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -265 80,555 -0.33 5.16 -1,367 415,664
2013-03-19 2013-03-15 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -318 80,820 -0.39 5.28 -1,679 426,730
2013-03-19 2013-03-18 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -24,736 7,517,368 -0.33 5.16 -127,638 38,789,619
2013-03-19 2013-03-15 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -29,719 7,542,104 -0.39 5.28 -156,916 39,822,309
2013-03-15 2013-03-14 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -5,020 2,455,035 -0.20 5.36 -26,907 13,158,988
2013-03-15 2013-03-13 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -7,733 2,460,055 -0.31 5.40 -41,758 13,284,297
2013-03-15 2013-03-14 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -85 41,901 -0.20 5.36 -456 224,589
2013-03-15 2013-03-13 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -131 41,986 -0.31 5.40 -707 226,724
2013-03-15 2013-03-14 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -166 81,138 -0.20 5.36 -890 434,900
2013-03-15 2013-03-13 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -256 81,304 -0.31 5.40 -1,382 439,042
2013-03-15 2013-03-14 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -15,480 7,571,823 -0.20 5.36 -82,973 40,584,971
2013-03-15 2013-03-13 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -23,848 7,587,303 -0.31 5.40 -128,779 40,971,436
2013-03-13 2013-03-12 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -6,346 2,467,788 -0.26 5.38 -34,141 13,276,699
2013-03-13 2013-03-11 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -4,118 2,474,134 -0.17 5.34 -21,990 13,211,876
2013-03-13 2013-03-12 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -107 42,117 -0.25 5.38 -576 226,589
2013-03-13 2013-03-11 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -70 42,224 -0.17 5.34 -374 225,476
2013-03-13 2013-03-12 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -210 81,560 -0.26 5.38 -1,130 438,793
2013-03-13 2013-03-11 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -136 81,770 -0.17 5.34 -726 436,652
2013-03-13 2013-03-12 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -19,569 7,611,151 -0.26 5.38 -105,281 40,947,992
2013-03-13 2013-03-11 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -12,700 7,630,720 -0.17 5.34 -67,818 40,748,045
2013-03-11 2013-03-08 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -5,154 2,478,252 -0.21 5.32 -27,419 13,184,301
2013-03-11 2013-03-07 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -12,701 2,483,406 -0.51 5.22 -66,299 12,963,379
2013-03-11 2013-03-08 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -88 42,294 -0.21 5.32 -468 225,004
2013-03-11 2013-03-07 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -215 42,382 -0.50 5.22 -1,122 221,234
2013-03-11 2013-03-08 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -171 81,906 -0.21 5.32 -910 435,740
2013-03-11 2013-03-07 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -420 82,077 -0.51 5.22 -2,192 428,442
2013-03-11 2013-03-08 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -15,892 7,643,420 -0.21 5.32 -84,545 40,662,994
2013-03-11 2013-03-07 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -39,168 7,659,312 -0.51 5.22 -204,457 39,981,609
2013-03-07 2013-03-06 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -3,839 2,496,107 -0.15 5.06 -19,425 12,630,301
2013-03-07 2013-03-05 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -4,039 2,499,946 -0.16 5.01 -20,235 12,524,729
2013-03-07 2013-03-06 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -65 42,597 -0.15 5.06 -329 215,541
2013-03-07 2013-03-05 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -69 42,662 -0.16 5.01 -346 213,737
2013-03-07 2013-03-06 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -11,841 7,698,480 -0.15 5.06 -59,915 38,954,309
2013-03-07 2013-03-05 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -12,454 7,710,321 -0.16 5.01 -62,395 38,628,708
2013-03-07 2013-03-06 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -127 82,497 -0.15 5.06 -643 417,435
2013-03-07 2013-03-05 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -134 82,624 -0.16 5.01 -671 413,946
2013-03-06 2013-03-06 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,651 46,813 -3.41 24.51 -40,466 1,147,387
2013-03-06 2013-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,132 48,464 -4.21 24.69 -52,639 1,196,576
2013-03-06 2013-03-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -417 50,596 -0.82 24.44 -10,191 1,236,566
2013-03-06 2013-03-06 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -98,349 2,740,937 -3.46 24.51 -2,410,534 67,180,366
2013-03-06 2013-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -126,868 2,839,286 -4.28 24.69 -3,132,371 70,101,971
2013-03-06 2013-03-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -24,783 2,966,154 -0.83 24.44 -605,697 72,492,804
2013-03-05 2013-03-04 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -5,145 2,503,985 -0.21 5.01 -25,776 12,544,965
2013-03-05 2013-03-01 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -7,635 2,509,130 -0.30 5.01 -38,251 12,570,741
2013-03-05 2013-03-04 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -88 42,731 -0.21 5.01 -441 214,082
2013-03-05 2013-03-01 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -130 42,819 -0.30 5.01 -651 214,523
2013-03-05 2013-03-04 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -170 82,758 -0.20 5.01 -852 414,618
2013-03-05 2013-03-01 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -253 82,928 -0.30 5.01 -1,268 415,469
2013-03-05 2013-03-04 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -15,865 7,722,775 -0.21 5.01 -79,484 38,691,103
2013-03-05 2013-03-01 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -23,548 7,738,640 -0.30 5.01 -117,975 38,770,586
2013-02-22 2013-02-20 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -1,998 2,516,765 -0.08 5.01 -10,010 12,608,993
2013-02-22 2013-02-20 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -34 42,949 -0.08 5.01 -170 215,174
2013-02-22 2013-02-20 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -6,160 7,762,188 -0.08 5.01 -30,862 38,888,562
2013-02-22 2013-02-20 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -66 83,181 -0.08 5.01 -331 416,737
2013-02-20 2013-02-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -10,076 2,518,763 -0.40 5.02 -50,582 12,644,190
2013-02-20 2013-02-15 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -2,967 2,528,839 -0.12 5.00 -14,835 12,644,195
2013-02-20 2013-02-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -171 42,983 -0.40 5.02 -858 215,775
2013-02-20 2013-02-15 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -51 43,154 -0.12 5.00 -255 215,770
2013-02-20 2013-02-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -334 83,247 -0.40 5.02 -1,677 417,900
2013-02-20 2013-02-15 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -99 83,581 -0.12 5.00 -495 417,905
2013-02-20 2013-02-19 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -31,075 7,768,348 -0.40 5.02 -155,996 38,997,107
2013-02-20 2013-02-15 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -9,148 7,799,423 -0.12 5.00 -45,740 38,997,115
2013-02-15 2013-02-14 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -2,951 2,531,806 -0.12 5.01 -14,785 12,684,348
2013-02-15 2013-02-13 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -5,763 2,534,757 -0.23 5.00 -28,815 12,673,785
2013-02-15 2013-02-14 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -51 43,205 -0.12 5.01 -256 216,457
2013-02-15 2013-02-13 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -98 43,256 -0.23 5.00 -490 216,280
2013-02-15 2013-02-14 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -98 83,680 -0.12 5.01 -491 419,237
2013-02-15 2013-02-13 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -191 83,778 -0.23 5.00 -955 418,890
2013-02-15 2013-02-14 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -9,100 7,808,571 -0.12 5.01 -45,591 39,120,941
2013-02-15 2013-02-13 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -17,770 7,817,671 -0.23 5.00 -88,850 39,088,355
2013-02-05 2013-02-01 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -9,769 2,540,520 -0.38 4.85 -47,380 12,321,522
2013-02-05 2013-02-01 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -164 43,354 -0.38 4.85 -795 210,267
2013-02-05 2013-02-01 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -30,134 7,835,441 -0.38 4.85 -146,150 38,001,889
2013-02-05 2013-02-01 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -322 83,969 -0.38 4.85 -1,562 407,250
2013-02-01 2013-01-31 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -18,537 2,550,289 -0.72 4.71 -87,309 12,011,861
2013-02-01 2013-01-30 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -11,105 2,568,826 -0.43 5.00 -55,525 12,844,130
2013-02-01 2013-01-31 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -314 43,518 -0.72 4.71 -1,479 204,970
2013-02-01 2013-01-30 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -188 43,832 -0.43 5.00 -940 219,160
2013-02-01 2013-01-31 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -57,165 7,865,575 -0.72 4.71 -269,247 37,046,858
2013-02-01 2013-01-30 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -34,248 7,922,740 -0.43 5.00 -171,240 39,613,700
2013-02-01 2013-01-31 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -613 84,291 -0.72 4.71 -2,887 397,011
2013-02-01 2013-01-30 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -367 84,904 -0.43 5.00 -1,835 424,520
2013-01-30 2013-01-29 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -15,320 2,579,931 -0.59 5.27 -80,736 13,596,236
2013-01-30 2013-01-28 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -16,660 2,595,251 -0.64 5.40 -89,964 14,014,355
2013-01-30 2013-01-29 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -260 44,020 -0.59 5.27 -1,370 231,985
2013-01-30 2013-01-28 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -282 44,280 -0.63 5.40 -1,523 239,112
2013-01-30 2013-01-29 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -47,247 7,956,988 -0.59 5.27 -248,992 41,933,327
2013-01-30 2013-01-28 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -51,377 8,004,235 -0.64 5.40 -277,436 43,222,869
2013-01-30 2013-01-29 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -507 85,271 -0.59 5.27 -2,672 449,378
2013-01-30 2013-01-28 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -551 85,778 -0.64 5.40 -2,975 463,201
2013-01-28 2013-01-25 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -13,790 2,611,911 -0.53 5.38 -74,190 14,052,081
2013-01-28 2013-01-24 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -36,324 2,625,701 -1.36 5.45 -197,966 14,310,070
2013-01-28 2013-01-25 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -234 44,562 -0.52 5.38 -1,259 239,744
2013-01-28 2013-01-24 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -616 44,796 -1.36 5.45 -3,357 244,138
2013-01-28 2013-01-25 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -456 86,329 -0.53 5.38 -2,453 464,450
2013-01-28 2013-01-24 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -1,201 86,785 -1.36 5.45 -6,545 472,978
2013-01-28 2013-01-25 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -42,525 8,055,612 -0.53 5.38 -228,784 43,339,193
2013-01-28 2013-01-24 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -111,022 8,098,137 -1.35 5.45 -605,070 44,134,847
2013-01-24 2013-01-23 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -25,354 2,662,025 -0.94 5.11 -129,559 13,602,948
2013-01-24 2013-01-22 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -14,966 2,687,379 -0.55 5.02 -75,129 13,490,643
2013-01-24 2013-01-23 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -430 45,412 -0.94 5.11 -2,197 232,055
2013-01-24 2013-01-22 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -254 45,842 -0.55 5.02 -1,275 230,127
2013-01-24 2013-01-23 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -839 87,986 -0.94 5.11 -4,287 449,608
2013-01-24 2013-01-22 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -495 88,825 -0.55 5.02 -2,485 445,902
2013-01-24 2013-01-23 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -78,188 8,210,159 -0.94 5.11 -399,541 41,953,912
2013-01-24 2013-01-22 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -46,153 8,288,347 -0.55 5.02 -231,688 41,607,502
2013-01-22 2013-01-18 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -19,080 2,702,345 -0.70 5.19 -99,025 14,025,171
2013-01-22 2013-01-17 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -12,615 2,721,425 -0.46 5.35 -67,490 14,559,624
2013-01-22 2013-01-18 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -324 46,096 -0.70 5.19 -1,682 239,238
2013-01-22 2013-01-17 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -214 46,420 -0.46 5.35 -1,145 248,347
2013-01-22 2013-01-18 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -58,838 8,334,500 -0.70 5.19 -305,369 43,256,055
2013-01-22 2013-01-17 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -38,903 8,393,338 -0.46 5.35 -208,131 44,904,358
2013-01-22 2013-01-18 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -631 89,320 -0.70 5.19 -3,275 463,571
2013-01-22 2013-01-17 4 CADX CADENCE PHARMACEUTICALS INC
Common Stock
S - Sale X -418 89,951 -0.46 5.35 -2,236 481,238
2013-01-18 2013-01-18 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other 66,462 159,896 71.13
2013-01-18 2013-01-18 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other -1,000,000 5,772,968 -14.76
2013-01-15 3 NONE Celator Pharmaceuticals Inc
Common Stock
2,222,175
2013-01-15 3 NONE Celator Pharmaceuticals Inc
Common Stock
16,733
2013-01-15 3 NONE Celator Pharmaceuticals Inc
Common Stock
5,868
2012-12-20 2012-12-18 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 20,000 20,000
2012-07-24 2012-07-24 4 DRTX Durata Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -16,529 0 -100.00
2012-07-24 2012-07-24 4 DRTX Durata Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -2,227,596 0 -100.00
2012-07-24 2012-07-24 4 DRTX Durata Therapeutics, Inc.
Common Stock
P - Purchase 5,777 22,306 34.95 9.00 51,993 200,754
2012-07-24 2012-07-24 4 DRTX Durata Therapeutics, Inc.
Common Stock
C - Conversion 16,529 16,529
2012-07-24 2012-07-24 4 DRTX Durata Therapeutics, Inc.
Common Stock
P - Purchase 778,536 3,006,132 34.95 9.00 7,006,824 27,055,188
2012-07-24 2012-07-24 4 DRTX Durata Therapeutics, Inc.
Common Stock
C - Conversion 2,227,596 2,227,596
2012-07-18 3 DRTX Durata Therapeutics, Inc.
Common Stock
6,250
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other 93,434 93,434
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other -1,200,000 6,772,968 -15.05
2004-05-12 3 NUVA NUVASIVE INC
Common Stock
8,000
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)